{
    "title": "AstraZeneca reports slide in sales and profits after snubbing Pfizer takeover but figures are better than expected",
    "url": "https://www.dailymail.co.uk/money/markets/article-3180495/AstraZeneca-reports-slide-sales-profits-snubbing-Pfizer-takeover-figures-better-expected.html",
    "date": "2015-07-30",
    "keywords": [
        "cent",
        "astrazeneca",
        "share",
        "cancer",
        "drug",
        "maker",
        "year",
        "takeover",
        "company",
        "pfizer",
        "yesterday",
        "secondquarter",
        "half",
        "dividend",
        "digit",
        "lung",
        "approval",
        "industry",
        "rise",
        "slide",
        "bid",
        "sank",
        "quarter",
        "demand",
        "blood",
        "thinner",
        "executive",
        "soriot",
        "resistance",
        "performance",
        "edf",
        "gas",
        "owner",
        "centrica",
        "attack",
        "tunisia",
        "debt",
        "crisis",
        "euro",
        "rollsroyce",
        "boss",
        "article",
        "loss",
        "percentage",
        "decline",
        "midsingle",
        "fallsoriot",
        "growth",
        "market",
        "iressa",
        "breast",
        "faslodex",
        "astra",
        "papadakis",
        "analyst",
        "bankit",
        "viagra",
        "expertise",
        "life",
        "defence",
        "pressure",
        "business",
        "patel",
        "fund",
        "manager",
        "investment",
        "management",
        "pipeline",
        "update",
        "firsthalf",
        "firm",
        "stock"
    ],
    "category": [
        "money",
        "markets"
    ]
}